Management of Anemia in Inflammatory Bowel Disease

Chris Sheasgreen

doi:10.58931/cibdt.2024.2335

Authors

Chris Sheasgreen, MD, FRCPC Memorial University, St. John’s, NL, Division of Digestive Care & Endoscopy, Department of Medicine, Dalhousie University, Halifax, NS

DOI:

https://doi.org/10.58931/cibdt.2024.2335

Abstract

Anemia is one of the most common complications of inflammatory bowel disease (IBD), with estimates of its prevalence varying from 9-74%. It is estimated to affect more than 1.2 billion people worldwide and evidence suggests that the incidence of anemia in people with IBD is almost double that of people without IBD (92.75 people with IBD per 1000 person-years vs 51.18 without IBD per 1000 person-years). Having a thorough approach to anemia in IBD is important because it is common and potentially dangerous, and because of its potential to arise from multiple different pathological and/or physiological processes.

Author Biography

Chris Sheasgreen, MD, FRCPC, Memorial University, St. John’s, NL, Division of Digestive Care & Endoscopy, Department of Medicine, Dalhousie University, Halifax, NS

Dr. Chris Sheasgreen is a gastroenterologist in Moncton, New Brunswick. He holds a Bachelor’s with Honours in Physiology at McGill and a Doctorate of Medicine from the University of Ottawa. He completed his residencies in Internal Medicine and Gastroenterology at McMaster University and completed a 2 year Advanced Fellowship in inflammatory bowel disease at Mount Sinai Hospital through the University of Toronto. He is currently practicing at The Moncton Hospital in New Brunswick, Canada. He is both Assistant Professor at Dalhousie University and Clinical Assistant Professor at Memorial University.

References

Gisbert JP, Gomollón F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol. 2008;103(5):1299-1307. doi:10.1111/j.1572-0241.2008.01846.x

Patel D, Yang YX, Trivedi C, Kavani H, Xie D, Medvedeva E, et al. Incidence, duration, and management of anemia: a nationwide comparison between IBD and non-IBD populations. Inflamm Bowel Dis. 2020;26(6):934-940. doi:10.1093/ibd/izz206

Camaschella C. Iron deficiency. Blood. 2019;133(1):30-39. doi:10.1182/blood-2018-05-815944

Buttarello M. Laboratory diagnosis of anemia: are the old and new red cell parameters useful in classification and treatment, how? Int J Lab Hematol. 2016;38 Suppl 1:123-132. doi:10.1111/ijlh.12500

Milovanovic T, Dragasevic S, Nikolic AN, Markovic AP, Lalosevic MS, Popovic DD, et al. Anemia as a problem: GP approach. Dig Dis. 2022;40(3):370-375. doi:10.1159/000517579

Day AS, Yao CK, Costello SP, Andrews JM, Bryant RV. Food avoidance, restrictive eating behaviour and association with quality of life in adults with inflammatory bowel disease: a systematic scoping review. Appetite. 2021;167:105650. doi:10.1016/j.appet.2021.105650

Limdi JK. Dietary practices and inflammatory bowel disease. Indian J Gastroenterol. 2018;37(4):284-292. doi:10.1007/s12664-018-0890-5

Turner D, Ricciuto A, Lewis A, D'Amico F, Dhaliwal J, Griffiths AM, et al. STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160(5):1570-1583. doi:10.1053/j.gastro.2020.12.031

Tefferi A. Anemia in adults: a contemporary approach to diagnosis. Mayo Clin Proc. 2003;78(10):1274-1280. doi:10.4065/78.10.1274

Bager P, Befrits R, Wikman O, Lindgren S, Moum B, Hjortswang H, et al. The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia. Scand J Gastroenterol. 2011;46(3):304-309. doi:10.3109/00365521.2010.533382

Colapinto CK, O'Connor DL, Tremblay MS. Folate status of the population in the Canadian Health Measures Survey. Cmaj. 2011;183(2):E100-106. doi:10.1503/cmaj.100568

Gold SL, Manning L, Kohler D, Ungaro R, Sands B, Raman M. Micronutrients and their role in inflammatory bowel disease: function, assessment, supplementation, and impact on clinical outcomes including muscle health. Inflamm Bowel Dis. 2023;29(3):487-501. doi:10.1093/ibd/izac223

Means RTJ, Brodsky RA. Diagnostic approach to anemia in adults. In: UptoDate, Elmore JG, (Editor): Wolters Kluwer; 2024.

Szczepiorkowski ZM, Dunbar NM. Transfusion guidelines: when to transfuse. Hematology Am Soc Hematol Educ Program. 2013;2013:638-644. doi:10.1182/asheducation-2013.1.638

Rizzo NS, Jaceldo-Siegl K, Sabate J, Fraser GE. Nutrient profiles of vegetarian and nonvegetarian dietary patterns. J Acad Nutr Diet. 2013;113(12):1610-1619. doi:10.1016/j.jand.2013.06.349

da Silva Lopes K, Yamaji N, Rahman MO, Suto M, Takemoto Y, Garcia-Casal MN, et al. Nutrition-specific interventions for preventing and controlling anaemia throughout the life cycle: an overview of systematic reviews. Cochrane Database Syst Rev. 2021;9(9):Cd013092. doi:10.1002/14651858.CD013092.pub2

Ning S, Zeller MP. Management of iron deficiency. Hematology Am Soc Hematol Educ Program. 2019;2019(1):315-322. doi:10.1182/hematology.2019000034

Moe S, Grill AK, Allan GM. Newer iron supplements for anemia. Can Fam Physician. 2019;65(8):556.

Hwang C, Ross V, Mahadevan U. Micronutrient deficiencies in inflammatory bowel disease: from A to zinc. Inflamm Bowel Dis. 2012;18(10):1961-1981. doi:10.1002/ibd.22906

Management of Anemia in Inflammatory Bowel Disease

Authors

DOI:

Abstract

Author Biography

Chris Sheasgreen, MD, FRCPC, Memorial University, St. John’s, NL, Division of Digestive Care & Endoscopy, Department of Medicine, Dalhousie University, Halifax, NS

References

Downloads

Published

How to Cite

Issue

Section

License

Summary

Open Access

Licence